Rockwell Medical, Inc.: Business Overview, Financials & Competitive Analysis
Rockwell Medical (NASDAQ: RMTI) develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Its hemodialysis concentrate products are used to sustain ...
Cyborg Score thesis
Established dialysis concentrate supplier with steady demand but faces profitability challenges and disruptive...
Read the full analyst-debate transcript →Get the Latest Rockwell Medical, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeRockwell Medical, Inc. Overview
Pro stress-test →Rockwell Medical (NASDAQ: RMTI) develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Its hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream.
Strategic Profile
Pro stress-test →The company pursues strategic diversification and global expansion efforts to capture new markets. However, the company is currently unprofitable and not forecast to become profitable over the next 3 years.
Competitive Landscape
Pro stress-test →Advances in alternative and at-home dialysis technologies by competitors threaten to erode Rockwell Medical's market share. The company competes in the specialized hemodialysis concentrate and dialysis supplies market serving clinical providers.
Industry Context
Rockwell Medical, Inc. operates in Healthcare - Specialty Pharmaceuticals & Medical Supplies.
Key facts
Founded: 1996 · Headquarters: Wixom, Michigan, US · Employees: 244